Published on
January 8, 2024
- 08:02 GMT
TECLens Chooses Validcare as CRO for its Presbyopia Study
Validcare’s approach is tailored to meet the regulatory and budgetary needs of small biotech. CASTLE PINES, CO, UNITED STATES, January 7, 2024 /EINPresswire.com/ -- TECLens, LLC has chosen Validcare to provide protocol development, e-source data …
Distribution channels:
Companies, Healthcare & Pharmaceuticals Industry
...
